Indeed, GSEA showed that the JAK_STAT pathway was enriched in ccRCC patients with low FDX1 expression, suggesting that FDX1 may have the potential to influence this well-known oncogenic pathway [41]. The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.